Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/emermed-2024-214565 | DOI Listing |
Publication Analysis
Top Keywords
correspondence 'four-factor
4
'four-factor prothrombin
4
prothrombin complex
4
complex concentrate
4
concentrate versus
4
versus andexanet
4
andexanet alfa
4
alfa reversal
4
reversal traumatic
4
traumatic brain
4
Similar Publications
Correspondence on 'Four-factor prothrombin complex concentrate versus andexanet alfa for the reversal of traumatic brain injuries' by Sadek .
Emerg Med J
November 2024
Inpatient Pharmacy, Trinity Health Ann Arbor, Ann Arbor, Michigan, USA.
Correspondence on 'Four-factor prothrombin complex concentrate versus andexanet alfa for the reversal of traumatic brain injuries' by Sadek .
Emerg Med J
November 2024
AstraZeneca, Wilmington, Delaware, USA.
The effects between andexanet alpha and four-factor prothrombin complex concentrate on DOACs anticoagulation reversal.
Crit Care
November 2024
Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning Province, China.
The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial.
Crit Care
February 2024
Inserm, U1216, CHU Grenoble Alpes, Grenoble Institute Neurosciences, Univ. Grenoble Alpes, 38000, Grenoble, France.
Four-Factor Prothrombin Complex Concentrate for Patients With Trauma.
JAMA
September 2023
Taipei City Hospital Zhongxing Branch, National Taiwan University Hospital, Taipei, Taiwan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!